ConductScience.org, home

Paper28293115

Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units.

Perrone V and 3 others. Clinicoecon Outcomes Res, 2017. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units. Papers, record 28293115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28293115

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units.
PubMed
Journal
Clinicoecon Outcomes Res
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.36
iCite
Revised in PubMed
2024-05-24
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Perrone VValentina
2Sangiorgi DDiego
3Buda SStefano
4Degli Esposti LLuca

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118087008Incidence and risk factors for psoriasis in the general population.Arch Dermatol2007https://conductscience.org/library/papers/18087008PubMed
224129141Continuous versus intermittent therapy for moderate-to-severe psoriasis.Clin Exp Rheumatol2013https://conductscience.org/library/papers/24129141PubMed
326538533Barriers to guideline-compliant psoriasis care: analyses and concepts.J Eur Acad Dermatol Venereol2016https://conductscience.org/library/papers/26538533PubMed
418835062Psoriasis: improving adherence to topical therapy.J Am Acad Dermatol2008https://conductscience.org/library/papers/18835062PubMed
523014338Global epidemiology of psoriasis: a systematic review of incidence and prevalence.J Invest Dermatol2013https://conductscience.org/library/papers/23014338PubMed
623149707Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.G Ital Dermatol Venereol2012https://conductscience.org/library/papers/23149707PubMed
725052261The economic burden of psoriasis: a systematic literature review.Expert Rev Pharmacoecon Outcomes Res2014https://conductscience.org/library/papers/25052261PubMed
823543539Topical treatments for chronic plaque psoriasis.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23543539PubMed
927789966Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting.Clinicoecon Outcomes Res2016https://conductscience.org/library/papers/27789966PubMed
1023437972Practicability of combined treatment with calcipotriol/betamethasone gel (Daivobet® Gel) and improvement of quality of life in patients with psoriasis.J Dtsch Dermatol Ges2013https://conductscience.org/library/papers/23437972PubMed
1121306785
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.
J Am Acad Dermatol2011https://conductscience.org/library/papers/21306785PubMed
1226010650Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.Australas J Dermatol2016https://conductscience.org/library/papers/26010650PubMed
1325521808
Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.
G Ital Dermatol Venereol2015https://conductscience.org/library/papers/25521808PubMed
1418728704Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris.Ther Clin Risk Manag2008https://conductscience.org/library/papers/18728704PubMed
1515624706The cost of psoriasis therapies: considerations for therapy selection.Dermatol Nurs2004https://conductscience.org/library/papers/15624706PubMed
1616050887Barriers to the treatment of hepatitis C. Patient, provider, and system factors.J Gen Intern Med2005https://conductscience.org/library/papers/16050887PubMed
1729387586Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability.Psoriasis (Auckl)2015https://conductscience.org/library/papers/29387586PubMed
1819641206Psoriasis.N Engl J Med2009https://conductscience.org/library/papers/19641206PubMed
1924684740Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.J Eur Acad Dermatol Venereol2014https://conductscience.org/library/papers/24684740PubMed
2022963128Adherence to medication in patients with psoriasis: a systematic literature review.Br J Dermatol2013https://conductscience.org/library/papers/22963128PubMed

See all 40 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
39959643Psoriasis: Unraveling Disease Mechanisms and Advancing Pharmacological and Nanotechnological Treatments.J Inflamm Res2025https://conductscience.org/library/papers/39959643PubMed
34067151Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics.Int J Mol Sci2021https://conductscience.org/library/papers/34067151PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28293115

GET https://conductscience.org/api/papers/v1/28293115/references?page=2